Faced with declining demand for cardiovascular stents and pacemakers, Boston Scientific recently saw its second-quarter sales barely pick up from a year ago.
Now the Natick, Mass.-based company is trying to save as much as $275 million in annual expenses, by cutting between 1,200 and 1,400 positions worldwide.
The cuts will be made through a combination of attrition and layoffs, the company said last week.
Boston Scientific hasn't specified which divisions it's downsizing the most, but there is one place it won't be laying off droves of workers: China. It plans to expand its Chinese operations and create 1,000 new jobs there, in order to take advantage of the country's rapid growth.
These young job seekers graduated into the worst labor market since the Great Depression.
|ESPN cuts familiar faces in major layoff|
|The 10 things United is doing to avoid another dust-up, drag-out passenger fiasco|
|NAFTA: Trump plays a risky game with $1.2 trillion in trade|
|Premarket: NAFTA; Tech earnings; U.S. tax plan|
|FCC chair unveils plan to roll back net neutrality|